Antioxidant improves smooth muscle sarco/endoplasmic reticulum Ca(2+)-ATPase function and lowers tyrosine nitration

Takeshi Adachi1, Reiko Matsui, Shanqin Xu

  • 1Vascular Biology Unit, Whitaker Cardiovascular Institute, Department of Medicine and Cardiothoracic Surgery, Boston University Medical Center, Boston, Mass, USA.

Insights

Antioxidants restore nitric oxide (NO) relaxation in hypercholesterolemia by improving vascular smooth muscle function. This study shows antioxidants reverse impaired sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA) activity in hypercholesterolemia.

Area of Science:

  • Cardiovascular Biology
  • Vascular Physiology
  • Pharmacology

Background:

  • Hypercholesterolemia (HC) impairs endothelial function and vascular smooth muscle response to nitric oxide (NO).
  • Oxidative stress in HC may negatively affect sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA) function, a key mediator of NO-induced relaxation.
  • The impact of antioxidants on NO-mediated vascular smooth muscle relaxation in HC is not well understood.

Purpose of the Study:

  • To investigate the effect of the antioxidant t-butylhydroxytoluene (BHT) on vascular smooth muscle SERCA activity and NO-induced relaxation in a rabbit model of hypercholesterolemia.
  • To determine if BHT can restore NO-mediated relaxation impaired by HC.
  • To explore the role of oxidative stress and SERCA function in HC-induced vascular dysfunction.

Main Methods:

  • Rabbits were fed a normal chow or a 0.5% cholesterol diet for 13 weeks. The antioxidant BHT (1%) was added to the HC diet during the final 3 weeks.
  • Vascular smooth muscle SERCA activity and NO-induced relaxation were measured in aortic tissues.
  • SERCA protein expression, 3-nitrotyrosine levels, and tyrosine-nitrated SERCA were assessed via immunoprecipitation.

Main Results:

  • Hypercholesterolemia impaired acetylcholine- and NO-induced relaxation, which were restored by BHT treatment.
  • Reduced aortic SERCA activity in HC rabbits was normalized by BHT without altering SERCA protein expression.
  • Increased 3-nitrotyrosine in HC aortas colocalized with SERCA, and tyrosine-nitrated SERCA was decreased by BHT, indicating reduced oxidative modification of SERCA.

Conclusions:

  • Antioxidant administration reverses impaired vascular smooth muscle SERCA function and restores NO-induced relaxation in hypercholesterolemia.
  • These beneficial effects are likely mediated by reducing the direct impact of reactive oxygen species on SERCA activity.
  • Targeting oxidative stress may be a viable strategy to improve vascular function in hypercholesterolemic conditions.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...